Loading articles...
IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
New insights from ATS 2026 reveal significant discrepancies between patient experiences and pulmonologist perceptions in IPF and PPF management.
ILD Diagnosis and Management: A Practical ATS 2026 Update
ATS 2026 provided a practical framework for interstitial lung disease (ILD) diagnosis and management, emphasising multidisciplinary team approaches and early antifibrotic initiation.
Sarcoidosis: Current Understanding of Diagnosis and Management
Sarcoidosis presents a diagnostic and therapeutic challenge. This review summarises current approaches to diagnosis, staging, and treatment strategies.
Systemic Sclerosis and Pulmonary Tuberculosis Risk
Patients with systemic sclerosis (SSc) face an elevated risk of opportunistic infections, particularly pulmonary tuberculosis (TB), especially in high-burden countries. This case highlights the need for heightened surveillance and tailored screening strateg...